MeiraGTx Holdings plc (MGTX) Cash Flow Statement

The negative OCF/NI ratio of -0.24 in Q2 2026 indicates that the reported net income, largely from a non-recurring collaboration milestone, did not translate into cash inflow. Instead, a $53.2M working capital outflow, likely reflecting the timing of receivables and payables, consumed cash. This pattern suggests the company's cash conversion is poor and highly volatile, dependent on the timing of milestone payments rather than operational efficiency.

The FCF margin's extreme volatility, ranging from -114.5% to +53.9% over the past ten quarters, confirms that the metric is not a reliable indicator of underlying business health. The recent negative FCF, despite a profitable quarter, underscores that the company's cash burn is structural, driven by its high fixed-cost R&D and manufacturing base, and is only temporarily offset by lumpy milestone receipts.

The seesaw pattern in working capital changes indicates that cash flow is heavily influenced by the timing of large collaboration payments and related expenses. The Q2 outflow likely represents the collection of receivables from the Q1 inflow, but the net effect over two quarters is a near-zero change, masking the underlying cash consumption from operations. This volatility makes it difficult to assess the efficiency of the company's cash cycle.

The decision to repurchase shares while operating with a $65.9M cash balance and a quarterly burn rate that can exceed $40M appears to prioritize short-term share count management over extending the cash runway. This allocation strategy warrants scrutiny, as it reduces the financial buffer available to fund clinical programs through potential delays or to navigate a challenging capital raising environment.